Eagle Pharmaceuticals Inc Financial Flexibility Index
Eagle Pharmaceuticals Inc financial flexibility index. Eagle Pharmaceuticals Inc (EGRX) has a Financial Flexibility Index of 0.00x as of June 2023. Free cash flow of $-120.00K (operating CF $-126.00K minus capex $6.00K) represents 0% of total liabilities ($152.78 Million). Explore Eagle Pharmaceuticals Inc (EGRX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Eagle Pharmaceuticals Inc (2012–2022)
Financial flexibility index of Eagle Pharmaceuticals Inc from 2012 to 2022. Historical Financial Flexibility Index trend for Eagle Pharmaceuticals Inc across 11 annual periods. Check total reinvestment intensity of Eagle Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Eagle Pharmaceuticals Inc Financial Flexibility Index by Year (2012–2022)
Eagle Pharmaceuticals Inc financial flexibility index by year from 2012 to 2022. Year-by-year free cash flow to debt coverage for Eagle Pharmaceuticals Inc. For the full cash flow conversion analysis, see EGRX cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.18x | $30.98 Million | $30.80 Million | $172.60 Million | ▼ -51.4% |
| 2021 | 0.37x | $28.54 Million | $28.22 Million | $77.28 Million | ▼ -50.6% |
| 2020 | 0.75x | $50.24 Million | $49.50 Million | $67.18 Million | ▼ -0.7% |
| 2019 | 0.75x | $56.76 Million | $55.99 Million | $75.38 Million | ▲ +11.6% |
| 2018 | 0.67x | $52.52 Million | $52.38 Million | $77.84 Million | ▼ -4.3% |
| 2017 | 0.71x | $64.11 Million | $58.92 Million | $90.92 Million | ▼ -40.5% |
| 2016 | 1.19x | $73.90 Million | $53.21 Million | $62.34 Million | ▲ +618.2% |
| 2015 | -0.23x | $-7.84 Million | $-9.72 Million | $34.26 Million | ▲ +66.3% |
| 2014 | -0.68x | $-13.80 Million | $-13.84 Million | $20.32 Million | ▼ -86.7% |
| 2013 | -0.36x | $-5.84 Million | $-5.88 Million | $16.05 Million | ▲ +49.5% |
| 2012 | -0.72x | $-15.52 Million | $-15.55 Million | $21.54 Million | — |